A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

NCT04512066 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

287

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia, Schizoaffective Disorder

Interventions

DRUG: RO6889450
DRUG: Placebo
DRUG: Risperidone

Sponsor

Hoffmann-La Roche